Defunct Company
Total Trials
6
As Lead Sponsor
As Collaborator
0
Total Enrollment
920
NCT01677299
Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DM
Phase: Phase 1/2
Role: Lead Sponsor
Start: May 31, 2012
Completion: Sep 30, 2012
NCT02291510
Assessing the PK of Met DR, Met IR, and Met XR in Healthy Subjects
Phase: Phase 1
Start: Oct 31, 2012
Completion: Dec 31, 2012
NCT01804842
Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM
Start: Dec 31, 2012
Completion: Apr 30, 2013
NCT01819272
Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks
Phase: Phase 2
Start: Apr 30, 2013
Completion: Sep 30, 2013
NCT01658514
Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction
Start: Jan 31, 2014
Completion: Jun 30, 2014
NCT02526524
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
Start: Sep 30, 2015
Completion: Sep 30, 2016